In partnership with

Beyond Solid Phase Synthesis:
Driving TIDES Process and Process Development Faster, Better, and More Sustainable

Watch on-demand now

As demand for increasingly complex TIDES therapeutics continues to rise, developers are looking beyond traditional solid-phase synthesis to improve efficiency, control, and sustainability.

Advances in enzymatic ligation, process analytical technology (PAT), and AI-driven process optimization are opening new possibilities for long-sequence synthesis—enhancing both speed and quality in development.

In this webinar, experts from Asymchem explore how integrated technologies and sustainable methodologies are redefining TIDES process development. They will share practical insights into how combining real-time analytics with data-driven process design can streamline scale-up and improve product consistency.

Key discussion points include:

  • How enzymatic methods are extending sequence length and improving overall process sustainability
  • The role of PAT and AI in achieving real-time process insight and control
  • Strategies for accelerating development timelines while maintaining purity and yield
Watch on-demand now →

Meet the Speakers

Dr. Raymond Ye

Senior Vice President
Analytical Development & Operations
Asymchem

Dr. Susan Li

Peptide Chief Scientist
Chemical Macromolecule Division
Asymchem

Dr. Xuecheng Jiao

Vice General Manager
Center of Synthetic Biology Technology
Asymchem

Don’t miss these expert insights:
watch now!

By ticking this box, you agree to receive emails from Citeline, C+D, and carefully selected partners
You agree Citeline and Asymchem may contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy policies of Citeline and Asymchem.
Pharma Ignite Inspire. Connect. Innovate.
Powered by

Copyright ©️ 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company. Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.